T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
976
Rapport Therapeutics
RAPP
$847M
| $21.5M | ﹤0.01% |
1,047,408
-313,197
| -23% | -$6.41M |
|
977
Evertec
EVTC
$2.19B
| $21.3M | ﹤0.01% |
628,605
-22,017
| -3% | -$746K |
|
978
Molson Coors Class B
TAP
$9.71B
| $21.2M | ﹤0.01% |
367,945
+26,933
| +8% | +$1.55M |
|
979
Celanese
CE
$5.13B
| $20.9M | ﹤0.01% |
153,460
+16,409
| +12% | +$2.23M |
|
980
Universal Health Services
UHS
$12.1B
| $20.8M | ﹤0.01% |
90,961
-3,484
| -4% | -$798K |
|
981
PTC Therapeutics
PTCT
$4.84B
| $20.8M | ﹤0.01% |
559,746
-46,930
| -8% | -$1.74M |
|
982
A10 Networks
ATEN
$1.29B
| $20.7M | ﹤0.01% |
1,430,260
+88,852
| +7% | +$1.28M |
|
983
BridgeBio Pharma
BBIO
$10.1B
| $20.6M | ﹤0.01% |
810,465
-14,353
| -2% | -$365K |
|
984
Travel + Leisure Co
TNL
$4.11B
| $20.4M | ﹤0.01% |
443,003
+42,274
| +11% | +$1.95M |
|
985
Nordson
NDSN
$12.8B
| $20.3M | ﹤0.01% |
77,279
+506
| +0.7% | +$133K |
|
986
Hilton Grand Vacations
HGV
$4.07B
| $20.3M | ﹤0.01% |
557,646
+19,388
| +4% | +$704K |
|
987
Evolent Health
EVH
$1.08B
| $20.2M | ﹤0.01% |
715,905
-7,054
| -1% | -$199K |
|
988
AES
AES
$9.15B
| $20.1M | ﹤0.01% |
1,001,794
+1,940
| +0.2% | +$38.9K |
|
989
Advanced Drainage Systems
WMS
$11.4B
| $20M | ﹤0.01% |
127,478
-11,726
| -8% | -$1.84M |
|
990
Invesco Senior Loan ETF
BKLN
$6.88B
| $20M | ﹤0.01% |
950,000
+293,900
| +45% | +$6.17M |
|
991
EyePoint Pharmaceuticals
EYPT
$919M
| $19.9M | ﹤0.01% |
2,492,213
-10,158
| -0.4% | -$81.2K |
|
992
Gulfport Energy Corp
GPOR
$3.06B
| $19.8M | ﹤0.01% |
130,997
+1,318
| +1% | +$199K |
|
993
Huazhu Hotels Group
HTHT
$11.3B
| $19.8M | ﹤0.01% |
531,486
-36,819
| -6% | -$1.37M |
|
994
Badger Meter
BMI
$5.34B
| $19.7M | ﹤0.01% |
90,026
+26,789
| +42% | +$5.85M |
|
995
Liberty Energy
LBRT
$1.8B
| $19.6M | ﹤0.01% |
1,027,999
-42,051
| -4% | -$803K |
|
996
Chemed
CHE
$6.67B
| $19.6M | ﹤0.01% |
32,584
-28,346
| -47% | -$17M |
|
997
Bunge Global
BG
$16.4B
| $19.4M | ﹤0.01% |
200,451
-3,560
| -2% | -$344K |
|
998
Erie Indemnity
ERIE
$17.7B
| $19.3M | ﹤0.01% |
35,813
+26,244
| +274% | +$14.2M |
|
999
Guardant Health
GH
$7.08B
| $19.3M | ﹤0.01% |
842,508
-533,166
| -39% | -$12.2M |
|
1000
UDR
UDR
$12.9B
| $19.1M | ﹤0.01% |
420,426
+5,976
| +1% | +$271K |
|